Wolters Kluwer Named Top Innovation Leader in Frost & Sullivan's 2025 Clinical Decision Support Radar Report
Wolters Kluwer Health has been recognized as a top clinical decision support system (CDSS) provider in Frost & Sullivan's 2025 Frost Radar Report. The company, which supplies the widely used UpToDate platform, emerged as the highest-ranking innovator and was named a "Company to Action" in the market evaluation. This recognition follows Wolters Kluwer's strong showing in the 2023 report, reinforcing its continued leadership in the field. Frost & Sullivan evaluated over 60 companies in the CDSS market, highlighting Wolters Kluwer's impressive research and development investments, recent product launches, and upcoming innovations. The report emphasizes the company's strategic integration of emerging technologies, particularly generative artificial intelligence (Gen AI), positioning it at the forefront of next-generation CDSS solutions. A key innovation spotlighted in the report is the introduction of UpToDate Enterprise Edition. This platform is designed to unify buyers, administrators, and care teams under a single interface, enhancing care delivery and maximizing return on investment. It offers advanced on-demand analytics, providing system-level insights into product usage, community trends, educational needs, and the broader impact of UpToDate on healthcare systems. "Frost Radar is a comprehensive analysis of the CDSS market," noted Dr. Rishi Pathak, Global Director of Healthcare & Life Sciences at Frost & Sullivan. "Our assessment indicates that Wolters Kluwer has achieved notable growth by emphasizing innovation and customer-centric solutions. Their strategy to integrate UpToDate into clinician workflows and expand into operational and financial processes further solidifies their leadership position." Wolters Kluwer Health has recently integrated UpToDate with several leading ambient AI platforms, including Abridge, Suki, and Microsoft. These integrations aim to improve the efficiency and effectiveness of clinical decision-making by leveraging the latest AI advancements. "Being named the innovation leader in the Frost Radar is a testament to our unwavering focus on innovation and connectivity," stated Greg Samios, CEO of Wolters Kluwer Health. "This recognition affirms our commitment to transforming healthcare through product enhancements and strategic collaborations. We are dedicated to helping providers make faster, smarter decisions throughout the care process, while also enabling organizations to optimize their UpToDate investment through insightful analytics, harmonized content, seamless integration, and AI-driven features." For detailed insights into Wolters Kluwer's achievements in the CDSS market, readers can explore the full Frost Radar report. Wolters Kluwer (Euronext: WKL) is a global leader in information, software solutions, and services for professionals in various fields, including healthcare, tax and accounting, financial and corporate compliance, legal and regulatory affairs, and corporate performance and ESG. By combining deep domain expertise with cutting-edge technology, the company helps its clients make critical decisions daily. In 2024, Wolters Kluwer reported annual revenues of €5.9 billion, serving customers in over 180 countries with operations in more than 40 countries. The company employs approximately 21,600 people worldwide and is headquartered in Alphen aan den Rijn, the Netherlands. To learn more about Wolters Kluwer, visit their website at www.wolterskluwer.com or follow them on LinkedIn, Facebook, YouTube, and Instagram. For additional news and updates from Wolters Kluwer, see their latest press releases.
